In this article, we will list the 5 Best Pure-Play Robotics Stocks to Buy Now. Please visit 10 Best Pure-Play Robotics Stocks to Buy Now if you’d like to see an extended list and our methodology.
5. Symbotic Inc. (NASDAQ:SYM)
Market Cap: $31.8 Billion
Potential Upside: 33.1%
Symbotic Inc. (NASDAQ:SYM) is among the best pure-play robotics stocks to buy now. The company is one of the clearest plays in large-scale warehouse robotics, as it positions itself as an AI-powered robotic and software platform for warehouse and distribution-center automation.
The stock had a strong run in 2025, gaining over 150%, but has been weak so far this year, with a decline of around 12%. The overall analyst consensus on the stock is mixed, with slightly over 40% of all analysts covering it assigning it a Buy rating. But the consensus 1-year median price target of $70 still implies a 33% potential upside.
That said, on March 16, Barclays raised its price target on Symbotic Inc. (NASDAQ:SYM) to $44 from $42, while maintaining an Underweight rating on the shares. The firm said signs of a short-cycle recovery are emerging across the industrial technology and distribution group, which means that the operating environment is improving for companies in that segment.
Symbotic’s financial position and growth profile are strong, according to recent disclosures. As of Q1 FY 2026, the company reported a solid backlog of $22.2 billion with blue-chip customers, and it sees a large “in-house” addressable market of $432 billion. These numbers indicate a substantial growth runway for the coming years.
Symbotic Inc. (NASDAQ:SYM) provides warehouse automation technology that uses robotics, software, and AI to improve distribution and supply chain operations for large retail, wholesale, and food and beverage customers.
4. Cognex Corp. (NASDAQ:CGNX)
Market Cap: $8.6 Billion
Potential Upside: 30.9%
Cognex Corp. (NASDAQ:CGNX) is among the best pure-play robotics stocks to buy now. Cognex has a strong presence in machine vision, a critical subsystem for industrial robotics, inspection, and factory automation. The company is well-positioned to benefit from increased adoption of robotics and automation in industries such as logistics, automotive, and manufacturing.
Supporting the positive investment case, Barclays raised its price target on Cognex Corp. (NASDAQ:CGNX) to $64 from $61, while maintaining its Overweight rating on March 16. The firm said signs of a short-cycle recovery are emerging across the industrial technology and distribution group, which means that the operating environment is improving for companies in that segment.
With that, nearly 75% of analysts covering the stock have assigned a Buy or equivalent rating. Despite a solid 42% share price return so far in 2026, the consensus 1-year median price target of $66.50 still implies a close to 31% potential upside.
Baron Fund, an investment management company, cited Cognex Corp. (NASDAQ:CGNX) among the top performance detractors in its Small Cap Fund’s Q4 2025 investor letter. However, the fund remained bullish on the stock given its fundamental strength. The portfolio managers said:
“Cognex Corporation is a leading provider of machine vision solutions. Shares declined during the quarter following weaker than-expected forward guidance that suggested continued growth but less acceleration than investors had anticipated. Cognex is an especially short-cycle player that is sensitive to changes in the broader industrial economy, which is currently operating below normalized levels. We expect the CAPEX cycle to continue in its Logistics segment, improve across Consumer Electronics, and management to spur growth with its “Emerging Customer Initiative.” Cognex’s competitive moat remains strong, the business has a stellar balance sheet, and margins are improving. We continue to like the stock.”
3. Teradyne Inc. (NASDAQ:TER)
Market Cap: $47.0 Billion
Potential Upside: 5.3%
Teradyne Inc. (NASDAQ:TER) is among the best pure-play robotics stocks to buy now. Teradyne’s exposure to robotics stems from its ownership of major collaborative-robotics platforms, including Universal Robots and MiR. The company envisages a $220 billion total addressable market for advanced robotics by 2033.
The stock has had a strong rally recently, with 54% returns in 2025 and robust outperformance in 2026, with 57% returns so far. Around two-thirds of analysts covering the stock still recommend a Buy or an equivalent rating.
On March 16, Teradyne’s robotics unit, Universal Robots, introduced the “UR AI Trainer” in partnership with AI infrastructure company Scale AI at NVIDIA’s GTC 2026 conference. The system uses imitation learning to capture motion, force, and vision data directly from robots operating in production environments.
Management said the platform is designed to address limitations in existing training methods, where models are often developed on non-production systems. Anders Beck, VP of AI Robotics Products at Universal Robots, said:
“Our customers, ranging from large enterprises to AI research labs, are no longer just asking for AI features. They need a way to collect high-fidelity, synchronized robot and vision data to train AI models on the same robots they intend to deploy. Our AI Trainer is the industry’s first direct lab-to-factory solution for AI model training.”
As one of its top performance contributors, investment management company Carillon Tower Advisers, in its Eagle Mid Cap Growth Fund’s Q4 2025 Investor Letter, highlighted this about Teradyne:
“Shares rose after the company reported very strong results on the back of strong demand for test equipment for artificial intelligence (AI)-related semiconductors. The company is also seeing potential market share gains that likewise could support revenue growth in 2026.”
Teradyne (NASDAQ:TER) designs, develops, and manufactures automated test equipment and advanced robotics systems. Its advanced robotics business includes collaborative robots and mobile robots that support manufacturing and warehouse operations for companies of all sizes.
2. Intuitive Surgical Inc. (NASDAQ:ISRG)
Market Cap: $167.5 Billion
Potential Upside: 29.3%
Intuitive Surgical Inc. (NASDAQ:ISRG) is among the best pure-play robotics stocks to buy now. The company is a leader in robotic-assisted, minimally invasive surgery with an installed base of over 12,000 Intuitive systems.
Intuitive Surgical Inc.’s (NASDAQ:ISRG) share price has been weak throughout this year and has declined nearly 16% year to date. Such a selloff drew attention from Citi analysts, who upgraded the stock from Neutral to Buy, according to a March 11 report. They, however, maintained their price target at $590, implying a 25% upside as of March 23.
Citi analysts believe that the U.S. medical technology sector still commands healthy fundamentals. Despite volatility and the share price decline, the firm believes ISRG could see double-digit sales growth, which should support strong earnings growth.
Underpinning the investment case for the stock, Polen Capital Management LLC initiated a 2.25% position in Intuitive Surgical as per its Q4 2025 “Polen Focus Growth Strategy” investor letter. The fund cited ISRG’s strong competitive position, business momentum, and valuation as the basis for the inclusion. They argued:
We initiated a 2.25% position in Intuitive Surgical who maintain a de facto monopoly in soft tissue robotic surgery globally. They have become the standard of care in many surgical modalities, while there are many more open and laparoscopic surgeries that can be converted to robotic over time. The barriers to entering their market are large based on decades of proven efficacy and safety, as well as the fact that most surgeons are trained on the company’s Da Vinci robots either in medical school or on the job, and they continue to innovate and distance themselves from potential entrants. The company recently fully launched its next-generation platform that should lead to accelerating procedure growth and revenue growth for years. Current results show this acceleration, and we see clear business momentum and a reasonable valuation considering this is an accelerating monopoly.
Intuitive Surgical Inc. (NASDAQ:ISRG) is the pioneer and a global technology leader in robotic-assisted, minimally invasive surgery. The company develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system.
1. Tesla Inc. (NASDAQ:TSLA)
Market Cap: $1.5 Trillion
Potential Upside: 25.4%
Tesla Inc. (NASDAQ:TSLA) is among the best pure-play robotics stocks to buy now. The company’s exposure to robotics is through its bipedal, autonomous humanoid robot, Optimus. According to some reports, this area is set for significant expansion, as Tesla has indicated long-term targets to produce 100 million Optimus robots annually. CEO Elon Musk is even looking at deploying tens of billions of robots over the next decade or so. Tesla’s recently announced Terafab chip-manufacturing initiative will support this expansion.
In a report early this week, Goldman Sachs noted that Tesla is gradually addressing the engineering challenges of its Optimus project as the company moves closer to commercialization. While the firm highlighted AI training as a crucial component for the robots, it indicated that Tesla plans to use these in internal operations initially to monitor performance and will deploy them commercially later.
Earlier, around March 18, Morgan Stanley argued that an unsupervised robotaxi fleet is the most important catalyst for the stock in 2026. The firm was encouraged after a tour of Tesla’s Giga Texas facility and believes that the successful rollout of robotaxis could create a flywheel across Tesla’s ecosystem. Morgan Stanley rates the stock an Equalweight with a $415 price target.
Meanwhile, investment management firm Tsai Capital Corporation also cited Tesla’s scope for substantial expansion in the robotics space as part of its investment case in its fourth quarter 2025 investor letter. The fund said:
“We also believe Tesla’s AI capabilities remain underestimated—and consequently undervalued. In fact, we think the company is at the beginning of a hypergrowth phase. We anticipate that it will eventually operate millions of autonomous vehicles and will own the majority of the autonomous market; that it will extend licenses for its self-driving software to rivals, generating recurrent revenues with 70-80% margins from those licenses; and that it will scale substantially in robotics.”
Tesla Inc. (NASDAQ:TSLA) is a developer, manufacturer, designer, lessor, and seller of electric vehicles and energy generation and storage systems. The company operates across the United States, China, and globally.
While we acknowledge the potential of TSLA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TSLA and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 11 Most Overvalued Companies According to the Media.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
